CN Stock MarketDetailed Quotes
002755 Beijing Aosaikang Pharmaceutical
- 13.08
- +0.26+2.03%
Market Closed Jan 3 15:00 CST
12.14BMarket Cap74.32P/E (TTM)
13.44High12.80Low72.26KlotVolume12.88Open12.82Pre Close95.02MTurnover0.78%Turnover RatioLossP/E (Static)928.16MShares15.1052wk High4.06P/B12.14BFloat Cap6.5052wk Low14.10Limit Up928.15MShs Float41.99Historical High11.54Limit Down4.99%Amplitude4.56Historical Low--Dividend TTM13.15Avg Price29.73KlotAsk--Div YieldTTM100Lot Size38.51KlotBid
Beijing Aosaikang Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 10.96%1.5B | 11.56%975.75M | 22.49%484.72M | -24.81%1.76B | -27.35%1.35B | -30.91%874.67M | -40.95%395.72M | -37.92%2.34B | -36.58%1.86B | -37.04%1.27B |
| Refunds of taxes and levies | -59.49%6.58M | -65.97%4.39M | ---- | -56.14%16.22M | 1,141.12%16.24M | --12.9M | --1.49M | --36.98M | --1.31M | ---- |
| Cash received relating to other operating activities | 87.68%145.83M | 116.42%99.01M | 1,121.69%84.09M | 69.05%71.15M | 47.66%77.7M | 42.33%45.75M | -61.57%6.88M | -58.42%42.09M | -50.13%52.62M | -21.69%32.14M |
| Cash inflows from operating activities | 14.29%1.65B | 15.63%1.08B | 40.76%568.82M | -23.66%1.85B | -24.49%1.45B | -28.11%933.32M | -41.28%404.1M | -37.50%2.42B | -37.00%1.92B | -36.73%1.3B |
| Goods services cash paid | 20.84%202.39M | -44.47%77.75M | 41.40%60.34M | 85.67%269.44M | 41.15%167.49M | 121.00%140.01M | 27.03%42.67M | 0.57%145.12M | -0.79%118.66M | -20.93%63.35M |
| Staff behalf paid | -22.50%156.59M | -23.76%118.25M | -20.77%67.1M | -12.81%260.9M | -8.03%202.06M | -1.95%155.1M | -9.74%84.69M | 0.89%299.23M | 1.29%219.68M | -6.38%158.19M |
| All taxes paid | 24.47%142.69M | 20.84%91.52M | 21.67%44.89M | -37.59%152.94M | -27.27%114.64M | -22.68%75.74M | -50.06%36.9M | -43.41%245.07M | -56.15%157.62M | -60.14%97.95M |
| Cash paid relating to other operating activities | -27.55%704.13M | -24.86%494.91M | -43.50%198.09M | -33.24%1.19B | -29.56%971.89M | -35.04%658.61M | -24.96%350.61M | -26.60%1.78B | -33.16%1.38B | -22.36%1.01B |
| Cash outflows from operating activities | -17.19%1.21B | -24.00%782.44M | -28.05%370.43M | -24.22%1.87B | -22.37%1.46B | -22.79%1.03B | -22.98%514.88M | -25.15%2.47B | -32.05%1.88B | -25.95%1.33B |
| Net cash flows from operating activities | 4,858.75%447.54M | 408.63%296.72M | 279.09%198.39M | 49.70%-26.57M | -123.36%-9.4M | -172.97%-96.14M | -665.11%-110.78M | -109.30%-52.81M | -85.68%40.25M | -114.02%-35.22M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 11.86%2.9B | 6.10%1.83B | -25.51%730M | 1.66%3.3B | 4.27%2.59B | 12.64%1.72B | 72.84%980M | 196.26%3.24B | 140.69%2.48B | 165.57%1.53B |
| Cash received from returns on investments | -4.80%17.8M | 12.97%13.43M | 22.62%7.66M | -1.42%25.29M | --18.7M | --11.88M | --6.25M | 229.12%25.65M | ---- | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 42.83%718.32K | 81.43%718.32K | ---- | -33.04%592.1K | 28.03%502.93K | 59.77%395.93K | 7,500.00%380K | -6.14%884.26K | -29.85%392.81K | -49.73%247.81K |
| Cash inflows from investing activities | 11.75%2.91B | 6.17%1.84B | -25.23%737.66M | 1.63%3.32B | 5.03%2.61B | 13.42%1.73B | 74.01%986.63M | 196.32%3.27B | 140.60%2.48B | 165.38%1.53B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 28.60%109.06M | 64.97%80.52M | 268.46%43.12M | -14.05%129.32M | -2.60%84.81M | -10.85%48.81M | -17.86%11.7M | 12.48%150.45M | -8.73%87.07M | -36.17%54.75M |
| Cash paid to acquire investments | 19.29%3.14B | 18.37%2.03B | -18.13%745M | -10.56%3.18B | -7.21%2.63B | -10.54%1.72B | 5.57%910M | 132.16%3.56B | 97.41%2.83B | 84.26%1.92B |
| Cash outflows from investing activities | 19.58%3.24B | 19.66%2.11B | -14.49%788.12M | -10.71%3.31B | -7.07%2.71B | -10.55%1.76B | 5.19%921.7M | 122.55%3.71B | 80.19%2.92B | 73.55%1.97B |
| Net cash flows from investing activities | -213.00%-330.53M | -760.74%-271.38M | -177.71%-50.46M | 102.63%11.56M | 75.82%-105.6M | 92.91%-31.53M | 121.00%64.93M | 22.04%-438.92M | 25.76%-436.74M | 20.71%-444.56M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | 62.48%206.38M | -71.86%35.74M | ---- | ---- | 33,750.85%127.02M | --127.02M | --127.02M |
| Cash from borrowing | -78.35%40M | 15.22%40M | -51.73%10M | 243.81%154.72M | 515.85%184.76M | --34.72M | --20.72M | --45M | --30M | ---- |
| Cash inflows from financing activities | -81.86%40M | 15.22%40M | -51.73%10M | 109.92%361.09M | 40.43%220.5M | -72.67%34.72M | --20.72M | 45,743.55%172.02M | --157.02M | --127.02M |
| Borrowing repayment | 65.63%84M | 305.49%84M | --40M | --65.72M | --50.72M | --20.72M | ---- | ---- | ---- | ---- |
| Dividend interest payment | -12.12%924.47K | -4.50%694.47K | 54.00%437.94K | -98.79%1.12M | -98.87%1.05M | -98.92%727.18K | --284.38K | -49.83%93.19M | -50.05%92.76M | -63.82%67.16M |
| Cash payments relating to other financing activities | 18.15%1.82M | 36.91%1.71M | --530.98K | 5.73%3.08M | 7.02%1.54M | -21.36%1.25M | ---- | -33.15%2.91M | --1.44M | --1.59M |
| Cash outflows from financing activities | 62.72%86.75M | 280.78%86.4M | 14,306.65%40.97M | -27.25%69.92M | -43.40%53.31M | -66.99%22.69M | --284.38K | -54.26%96.11M | -56.33%94.2M | -66.56%68.75M |
| Net cash flows from financing activities | -127.96%-46.75M | -485.91%-46.4M | -251.58%-30.97M | 283.57%291.17M | 166.14%167.19M | -79.36%12.02M | --20.43M | 136.19%75.91M | 129.12%62.82M | 128.34%58.27M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 205.77%4.23M | -41.02%3.84M | 154.42%727.93K | -107.69%-1.2M | -76.60%1.38M | 13,878.56%6.51M | -35,517.43%-1.34M | 80,398.73%15.6M | 109,764.09%5.92M | 689.96%46.6K |
| Net increase in cash and cash equivalents | 39.06%74.49M | 84.22%-17.22M | 539.81%117.69M | 168.70%274.97M | 116.34%53.57M | 74.11%-109.13M | 90.76%-26.76M | -95.16%-400.22M | 37.32%-327.75M | 18.17%-421.47M |
| Add:Begin period cash and cash equivalents | 36.15%1.04B | 36.15%1.04B | 36.15%1.04B | -34.48%760.68M | -34.48%760.68M | -34.48%760.68M | -34.48%760.68M | -15.01%1.16B | -15.01%1.16B | -15.01%1.16B |
| End period cash equivalent | 36.34%1.11B | 56.31%1.02B | 57.15%1.15B | 36.15%1.04B | -2.27%814.24M | -11.89%651.55M | -15.76%733.92M | -34.48%760.68M | -1.18%833.14M | -13.10%739.43M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
